No or only population-specific effect of PON1 on human longevity: A comprehensive meta-analysis

Anselmi, 2009, Association of the FOXO3A locus with extreme longevity in a Southern Italian Centenarian Study, Rejuvenation Res., 12, 95, 10.1089/rej.2008.0827 Aviram, 2000, Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice, Am. J. Clin. Nutr., 71, 1062, 10.1093/ajcn/71.5.1062 Balcerzyk, 2008, Protective effect of R allele of PON1 gene on the coronary artery disease in the presence of specific genetic background, Dis. Markers, 24, 81, 10.1155/2008/789291 Berliner, 1995, Atherosclerosis: basic mechanisms, oxidation, inflammation, and genetics, Circulation, 91, 2488, 10.1161/01.CIR.91.9.2488 Bhattacharyya, 2008, Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk, JAMA, 299, 1265, 10.1001/jama.299.11.1265 Blanché, 2001, A study of French centenarians: are ACE and APOE associated with longevity? C, R. Acad. Sci. III, 324, 129, 10.1016/S0764-4469(00)01274-9 Boesch-Saadatmandi, C., Niering, J., Minihane, A.M., Wiswedel, I., Gardeman, A., Wolffram, S., Rimbach, G. Impact of apolipoprotein E genotype and dietary quercetin on paraoxonase 1 status in apoE3 and apoE4 transgenic mice. Atherosclerosis, in press. Bonafè, 2002, Genetic analysis of Paraoxonase (PON1) locus reveals an increased frequency of Arg192 allele in centenarians, Eur. J. Hum. Genet., 10, 292, 10.1038/sj.ejhg.5200806 Campo, 2004, Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians, Exp. Gerontol., 39, 1089, 10.1016/j.exger.2004.03.017 Cellini, 2006, Association analysis of the paraoxonase-1 gene with Alzheimer's disease, Neurosci. Lett., 408, 199, 10.1016/j.neulet.2006.08.074 Cherki, 2007, Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging, Exp. Gerontol., 42, 815, 10.1016/j.exger.2007.04.006 Christensen, 2006, The quest for genetic determinants of human longevity: challenges and insights, Nat. Rev. Genet., 7, 436, 10.1038/nrg1871 Christiansen, 2004, Paraoxonase 1 polymorphisms and survival, Eur. J. Hum. Genet., 12, 843, 10.1038/sj.ejhg.5201235 Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, 921, 10.1126/science.8346443 Curtin, 2008, Resveratrol induces catalytic bioscavenger paraoxonase 1 expression and protects against chemical warfare nerve agent toxicity in human cell lines, J. Cell. Biochem., 103, 1524, 10.1002/jcb.21543 DerSimonian, 1983, Evaluation the effect of coaching on SAT scores: a meta-analysis, Harvard Educ. Rev., 53, 1, 10.17763/haer.53.1.n06j5h5356217648 Dietrich, 2005, Associations between apolipoprotein E genotype and circulating F2-isoprostane levels in humans, Lipids., 40, 329, 10.1007/s11745-006-1390-4 Ferré, 2003, Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population, Clin. Chem., 49, 1491, 10.1373/49.9.1491 Flachsbart, 2009, Association of FOXO3A variation with human longevity confirmed in German centenarians, Proc. Natl. Acad. Sci. USA, 106, 2700, 10.1073/pnas.0809594106 Gong, 2009, Quercetin up-regulates paraoxonase 1 gene expression with concomitant protection against LDL oxidation, Biochem. Biophys. Res. Commun., 379, 1001, 10.1016/j.bbrc.2009.01.015 He, 2006, Gln192Arg polymorphism in paraoxonase 1 gene is associated with Alzheimer disease in a Chinese Han ethnic population. Chin Med J (Engl), 119, 1204 Heijmans, 2000, Common paraoxonase gene variants, mortality risk and fatal cardiovascular events in elderly subjects, Atherosclerosis, 149, 91, 10.1016/S0021-9150(99)00311-1 Herskind, 1996, The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870–1900, Hum. Genet., 97, 319, 10.1007/BF02185763 Hjelmborg, 2006, Genetic influence on human lifespan and longevity, Hum. Genet., 119, 312, 10.1007/s00439-006-0144-y Jarvik, 2002, Vitamin C and E intake is associated with increased paraoxonase activity, Arterioscler. Thromb. Vasc. Biol., 22, 1329, 10.1161/01.ATV.0000027101.40323.3A Jarvik, 2003, Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease, Arterioscler. Thromb. Vasc. Biol., 23, 1465, 10.1161/01.ATV.0000081635.96290.D3 Jofre-Monseny, 2008, Impact of apoE genotype on oxidative stress, inflammation and disease risk, Mol. Nutr. Food Res., 52, 131, 10.1002/mnfr.200700322 Lakshman, 2009, Is alcohol beneficial or harmful for cardioprotection?, Genes Nutr. Li, 2009, Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations, Hum. Mol. Genet., 18, 4897, 10.1093/hmg/ddp459 Lescai, 2009, PON1 is a longevity gene: results of a meta-analysis, Ageing Res. Rev., 8, 277, 10.1016/j.arr.2009.04.001 Mackness, 2001, Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?, Arterioscler. Thromb. Vasc. Biol., 21, 1451, 10.1161/hq0901.094247 Marchegiani, 2006, Paraoxonase activity and genotype predispose to successful aging, J. Gerontol. A. Biol. Sci. Med. Sci., 61, 541, 10.1093/gerona/61.6.541 McGue, 1993, Longevity is moderately heritable in a sample of Danish twins born 1870–1880, J. Gerontol., 48, B237, 10.1093/geronj/48.6.B237 Nassar, 2002, Relation between butyrylcholinesterase K variant, paraoxonase 1 (PON1) Q and R and apolipoprotein E epsilon 4 genes in early-onset coronary artery disease, Clin. Biochem., 35, 205, 10.1016/S0009-9120(02)00296-5 Nebel, 2005, No association between microsomal triglyceride transfer protein (MTP) haplotype and longevity in humans, Proc. Natl. Acad. Sci. USA, 102, 7906, 10.1073/pnas.0408670102 Nishio, 1997, Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme's free thiols, Biochem. Biophys. Res. Commun., 236, 289, 10.1006/bbrc.1997.6961 Novelli, 2008, Lack of replication of genetic associations with human longevity, Biogerontology, 9, 85, 10.1007/s10522-007-9116-4 Panza, 2004, Vascular genetic factors and human longevity, Mech. Ageing Dev., 125, 169, 10.1016/j.mad.2003.12.005 Pauk, 2007, Paraoxonase 1 gene polymorphism 192Q/R in old men and long-livers from Tatars ethnic group, Mol. Biol. (Mosk), 41, 601, 10.1134/S0026893307040036 Pawlikowska, 2009, Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity, Aging Cell., 8, 460, 10.1111/j.1474-9726.2009.00493.x R Development Core Team, 2008. A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN: 3-900051r-r07-0. Rao, 2003, Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans, Metabolism, 52, 1287, 10.1016/S0026-0495(03)00191-4 Rea, 2004, Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis, Exp. Gerontol., 39, 629, 10.1016/j.exger.2003.11.019 Seres, 2004, Study of factors influencing the decreased HDL associated PON1 activity with aging, Exp. Gerontol., 39, 59, 10.1016/j.exger.2003.08.001 Skytthe, 2003, Longevity studies in GenomEUtwin, Twin Res., 6, 448, 10.1375/136905203770326457 Steinberg, 1997, Lewis A. Conner memorial lecture. Oxidative modification of LDL and atherogenesis, Circulation, 95, 1062, 10.1161/01.CIR.95.4.1062 Stewart, 1993, Meta-analysis of the literature or of individual patient data: is there a difference?, Lancet, 341, 418, 10.1016/0140-6736(93)93004-K Talmud, 2005, The significant increase in cardiovascular disease risk in APOEepsilon4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4, Ann. Hum. Genet., 69, 613, 10.1111/j.1529-8817.2005.00205.x Tan, 2006, Genetic association analysis of human longevity in cohort studies of elderly subjects: an example of the PON1 gene in the Danish 1905 birth cohort, Genetics, 172, 1821, 10.1534/genetics.105.050914 Thomàs-Moyà, 2007, Paraoxonase 1 response to a high-fat diet: gender differences in the factors involved, Mol. Med., 13, 203, 10.2119/2006-00078.Thomas-Moya Tomás, 2000, Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients, Arterioscler. Thromb. Vasc. Biol., 20, 2113, 10.1161/01.ATV.20.9.2113 Tomás, 2001, Interaction between the Gln-Arg 192 variants of the paraoxonase gene and oleic acid intake as a determinant of high-density lipoprotein cholesterol and paraoxonase activity, Eur. J. Pharmacol., 432, 121, 10.1016/S0014-2999(01)01482-0 Tomás, 2002, Paraoxonase1-192 polymorphism modulates the effects of regular and acute exercise on paraoxonase1 activity, J. Lipid Res., 43, 713, 10.1016/S0022-2275(20)30113-9 Wheeler, 2004, Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies, Lancet, 363, 689, 10.1016/S0140-6736(04)15642-0 Willcox, 2008, FOXO3A genotype is strongly associated with human longevity, Proc. Natl. Acad. Sci. USA, 105, 13987, 10.1073/pnas.0801030105 Wilson, 1996, Apolipoprotein E alleles and risk of coronary disease. A meta-analysis, Arterioscler. Thromb. Vasc. Biol., 16, 1250, 10.1161/01.ATV.16.10.1250